Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-06

Clinical Trial Update: The Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial II [Phase 2]

View source ↗

Summary

Phase 2 trial investigating acute arterial pressure reduction for intracerebral hemorrhage has been terminated. Sponsor: University of Alberta.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Alberta | Conditions: Intracerebral Hemorrhage | Phase 2 | Status: TERMINATED